ALT Earnings

Quarterly EPS
$-0.32
Q3 2024
$-0.33
Q4 2024
$-0.26
Q1 2025
$-0.27
Q2 2025
$-0.21
Q3 2025
$-0.26
Q4 2025
$-0.18
Q1 2026
$-0.12
Q2 2026
Latest RevenueN/A
Latest Net Income-22825000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.120-22825000-100.0%+55.6%
Q1 2026-$0.180-22563000-100.0%+30.8%
Q4 2025-$0.2626.0K-27358000+420.0%+21.2%
Q3 2025-$0.215.0K-19014000+0.0%+34.4%
Q2 2025-$0.275.0K-22146000+0.0%+22.9%
Q1 2025-$0.265.0K-19575000+0.0%+23.5%
Q4 2024-$0.335.0K-23180000-86.5%+38.9%
Q3 2024-$0.325.0K-22845000-98.6%+17.9%
Q2 2024-$0.355.0K-24640000
Q1 2024-$0.345.0K-24394000
Q4 2023-$0.5437.0K-31641000
Q3 2023-$0.39362.0K-20671000
Altimmune (ALT) — Earnings